Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?
- PMID: 18725646
- DOI: 10.1200/JCO.2008.18.0851
Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?
Comment on
-
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.J Clin Oncol. 2008 Oct 20;26(30):4875-82. doi: 10.1200/JCO.2008.16.3832. Epub 2008 Aug 25. J Clin Oncol. 2008. PMID: 18725648 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical